Gabapentin Suspension
Product Images NDC 59762-5050

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 59762-5050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Equation (Gabapentin 01)

A text panel showing the formula for calculating creatinine clearance (CLCr). The formula uses age, weight, serum creatinine level, and a factor for female patients to estimate kidney function. This is a common clinical calculation included in drug labeling to guide dosing considerations.*

FDA Label Image

Chemical Structure (Gabapentin 02)

Chemical structure of gabapentin, the active ingredient in GABAPENTIN oral suspension 250 mg/5 mL by Mylan Pharmaceuticals Inc.*

FDA Label Image

Figure 1 (Gabapentin 03)

A line graph showing mean pain scores over an 8-week period, comparing Placebo and Gabapentin 3600 mg/day. The x-axis represents weeks from baseline to week 8, including a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin shows a decreasing pain score trend, while Placebo remains relatively stable.*

FDA Label Image

Figure 2 (Gabapentin 04)

A line graph showing mean pain score over 7 weeks for three groups: placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period. Gabapentin groups show a decline in mean pain scores compared to placebo.*

FDA Label Image

Figure 3 (Gabapentin 05)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) treatments across two studies. The vertical axis shows percentage from 0% to 100%. Study 1 compares PBO (12%) to GBP 3600 mg (29%), and Study 2 compares PBO (14%) to GBP 1800 mg (32%) and GBP 2400 mg (34%), with statistical significance indicated.*

FDA Label Image

Figure 4 (Gabapentin 06)

A scatter plot comparing percentage difference on the y-axis and daily dose in mg on the x-axis for three studies labeled a, b, and c. The chart shows data points for doses at 600, 900, 1200, and 1800 mg with varying percentage differences, and a legend identifies the three studies by different colored squares.*

FDA Label Image

Logo (Gabapentin 07)

Label excerpt of GABAPENTIN oral suspension distributed by Greenstone LLC, Peapack, NJ 07977, featuring the Greenstone Brand logo and distributor information.*

FDA Label Image

Logo (Gabapentin 07a)

FDA Label Image

Principal Display Panel (100 mg Bottle Label)

Label for Greenstone brand gabapentin capsules 100 mg. The label includes dosage form as capsules, quantity of 100 capsules, and directs dispensing with a medication guide. It shows storage instructions between 15°C and 30°C, with a note to dispense in child-resistant containers. Distributed by Greenstone LLC, Peapack, NJ, made in India, with NDC 59762-4030-1.*

FDA Label Image

Principal Display Panel (300 mg Bottle Label)

Label for gabapentin capsules 300 mg by Greenstone LLC. The label includes storage instructions, dosage guidance, and notes the product is made in India. It specifies a package size of 100 capsules and includes NDC 59762-4135-1 with barcodes. The product is prescription only.*

FDA Label Image

Principal Display Panel (400 mg Bottle Label)

Label for gabapentin capsules, 400 mg strength by Greenstone LLC. The label includes storage instructions, dosage note indicating each capsule contains 400 mg gabapentin, quantity of 100 capsules, and the distributor location (Peapack, NJ). The label also features a barcode and states the capsules are prescription only.*

FDA Label Image

Principal Display Panel (600 mg Bottle Label)

Label for Gabapentin tablets, 600 mg, distributed by Greenstone LLC. The label indicates the product contains 100 tablets and is a prescription medication. Storage instructions specify 25°C (77°F) with permitted excursions between 15°C and 30°C. Each tablet contains 600 mg of gabapentin, and the label notes the product is made in India.*

FDA Label Image

Principal Display Panel (800 mg Bottle Label)

Label for Greenstone brand gabapentin tablets, 800 mg strength. The label indicates a package of 100 tablets with prescription use only. It includes storage instructions, dosage note to see package insert, distributor information (Greenstone LLC, Peapack, NJ), and states the product is made in India. The label features barcodes and a National Drug Code (NDC 59762-4460-1).*

FDA Label Image

Principal Display Panel (470 mL Bottle Label)

Label for GABAPENTIN oral solution, 250 mg per 5 mL, a prescription human drug suspension by Greenstone LLC distributed by Mylan Pharmaceuticals Inc. The 470 mL bottle label includes storage instructions (2°C to 8°C), dosage note to see prescribing information, a drug safety warning to keep out of reach of children, and state that each 5 mL contains 250 mg gabapentin. The product is made in India.*

FDA Label Image

Principal Display Panel (470 mL Bottle Carton)

Carton label for Gabapentin oral solution 250 mg per 5 mL, a human prescription drug suspension by Mylan Pharmaceuticals Inc. The label is for a 470 mL bottle distributed by Greenstone LLC, Peapack, NJ. It includes storage instructions, dosing guidance, barcodes, and a caution to keep out of children's reach.*

FDA Label Image

Principal Display Panel (470 mL Bottle Label)

Label for GABAPENTIN oral solution, 250 mg per 5 mL, 470 mL bottle. The product is a prescription human drug labeled as Greenstone Brand, distributed by Mylan Pharmaceuticals Inc. The label instructs refrigeration at 2°C to 8°C (36°F to 46°F), with dosage and safety information, including a medication guide and child safety warnings.*

FDA Label Image

Principal Display Panel (470 mL Bottle Carton)

Packaging label for Greenstone brand gabapentin oral solution, 250 mg per 5 mL. The label indicates a 470 mL bottle, with instructions to always dispense with medication guide. Distributed by Greenstone LLC, Peapack, NJ, and made in India. Storage instructions specify refrigeration between 2°C to 8°C (36°F to 46°F).*

FDA Label Image

Gabapentin 17

Label for gabapentin oral solution 250 mg per 5 mL, a human prescription drug suspension. The label shows NDC 59762-5050-7 and volume 470 mL. It includes storage instructions to refrigerate at 2°C to 8°C (36°F to 46°F), dosage and use note to see prescribing information, and a warning to keep out of reach of children. Distributed by Greenstone LLC, Peapack, NJ.*

FDA Label Image

Gabapentin 18

Packaging label for Greenstone brand gabapentin oral solution, 250 mg per 5 mL, in a 470 mL bottle. The label includes dosing information, storage instructions to keep refrigerated between 2°C to 8°C (36°F to 46°F), and safety precautions to keep out of the reach of children. Distributed by Greenstone LLC, Peapack, NJ, with manufacturing indicated as made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.